| scholarly article | Q13442814 |
| P2093 | author name string | Wasylyk B | |
| Gutman A | |||
| P2860 | cites work | Isolation of human cDNA clones of ski and the ski-related gene, sno | Q24635631 |
| Phorbol ester-inducible genes contain a common cis element recognized by a TPA-modulated trans-acting factor | Q28288345 | ||
| The jun proto-oncogene is positively autoregulated by its product, Jun/AP-1 | Q28291340 | ||
| How eukaryotic transcriptional activators work | Q29618289 | ||
| Inducibility of kappa immunoglobulin enhancer-binding protein Nf-kappa B by a posttranslational mechanism | Q29619866 | ||
| NF-kappa B: a pleiotropic mediator of inducible and tissue-specific gene control | Q29620172 | ||
| Autoregulation of fos: the dyad symmetry element as the major target of repression. | Q33576167 | ||
| Activation of the polyomavirus enhancer by a murine activator protein 1 (AP1) homolog and two contiguous proteins | Q33638518 | ||
| The v-myb oncogene product binds to and activates the promyelocyte-specific mim-1 gene | Q35926914 | ||
| An AP1-binding site in the c-fos gene can mediate induction by epidermal growth factor and 12-O-tetradecanoyl phorbol-13-acetate | Q36768426 | ||
| Cross-binding of factors to functionally different promoter elements in c-fos and skeletal actin genes | Q36777802 | ||
| Calcium and growth factor pathways of c-fos transcriptional activation require distinct upstream regulatory sequences | Q36791640 | ||
| Definition of an Ets1 protein domain required for nuclear localization in cells and DNA-binding activity in vitro | Q36798329 | ||
| Mutation of the c-fos gene dyad symmetry element inhibits serum inducibility of transcription in vivo and the nuclear regulatory factor binding in vitro | Q36837457 | ||
| 12-O-tetradecanoyl-phorbol-13-acetate induction of the human collagenase gene is mediated by an inducible enhancer element located in the 5'-flanking region | Q36842600 | ||
| AP1, a composite transcription factor implicated in abnormal growth control | Q38246033 | ||
| trans-repression of the mouse c-fos promoter: a novel mechanism of Fos-mediated trans-regulation. | Q38342714 | ||
| PEA3 is a nuclear target for transcription activation by non-nuclear oncogenes | Q38343225 | ||
| The c-fos serum response element responds to protein kinase C-dependent and -independent signals but not to cyclic AMP. | Q38347607 | ||
| 'Nuclear' oncogenes convert extracellular stimuli into changes in the genetic program | Q38637970 | ||
| Modularity in promoters and enhancers | Q38667179 | ||
| Trans-activation by the c-myb proto-oncogene | Q40520389 | ||
| Point mutational analysis of the human c-fos serum response factor binding site | Q40521350 | ||
| Purification of intercalator-released p67, a polypeptide that interacts specifically with the c-fos serum response element | Q40562234 | ||
| Two distinct cellular phosphoproteins bind to the c-fos serum response element | Q40818085 | ||
| Repression of c-fos transcription is mediated through p67SRF bound to the SRE. | Q40819071 | ||
| DNA replication origin and transcriptional enhancer in c-myc gene share the c-myc protein binding sequences | Q40820674 | ||
| An initiation site of DNA replication with transcriptional enhancer activity present upstream of the c-myc gene | Q41092972 | ||
| Transforming but not immortalizing oncogenes activate the transcription factor PEA1 | Q41107103 | ||
| Identification and purification of a polypeptide that binds to the c-fos serum response element | Q41926839 | ||
| Requirement for fos gene expression in the transcriptional activation of collagenase by other oncogenes and phorbol esters | Q42502049 | ||
| The c-Ha-ras oncogene and a tumor promoter activate the polyoma virus enhancer | Q42808894 | ||
| Transcriptional activation by the v-myb oncogene and its cellular progenitor, c-myb | Q46044395 | ||
| Viral myb oncogene encodes a sequence-specific DNA-binding activity. | Q46760013 | ||
| A Harvey-ras responsive transcription element is also responsive to a tumour-promoter and to serum | Q58985113 | ||
| The ability of a ternary complex to form over the serum response element correlates with serum inducibility of the human c-fos promoter | Q69177591 | ||
| P433 | issue | 7 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 2241-2246 | |
| P577 | publication date | 1990-07-01 | |
| P1433 | published in | The EMBO Journal | Q1278554 |
| P1476 | title | The collagenase gene promoter contains a TPA and oncogene-responsive unit encompassing the PEA3 and AP-1 binding sites | |
| P478 | volume | 9 |
| Q34776433 | A compilation of composite regulatory elements affecting gene transcription in vertebrates |
| Q41546059 | A regulatory element that mediates co-operation between a PEA3-AP-1 element and an AP-1 site is required for phorbol ester induction of urokinase enhancer activity in HepG2 hepatoma cells |
| Q36572376 | A role for the ETS domain transcription factor PEA3 in myogenic differentiation |
| Q35080591 | Age-associated reduction of cellular spreading/mechanical force up-regulates matrix metalloproteinase-1 expression and collagen fibril fragmentation via c-Jun/AP-1 in human dermal fibroblasts |
| Q36280202 | Age-related reduction of dermal fibroblast size up-regulates multiple matrix metalloproteinases as observed in aged human skin in vivo |
| Q34316542 | An inhibitor domain in c-Fos regulates activation domains containing the HOB1 motif. |
| Q38331502 | Autocrine growth induced by kinase type oncogenes in myeloid cells requires AP-1 and NF-M, a myeloid specific, C/EBP-like factor |
| Q42787641 | Balance between polyoma enhancing activator 3 and activator protein 1 regulates Helicobacter pylori-stimulated matrix metalloproteinase 1 expression |
| Q42846610 | Basic calcium phosphate crystals activate c-fos expression through a Ras/ERK dependent signaling mechanism |
| Q40641649 | Cell-specific regulation of oncogene-responsive sequences of the c-fos promoter |
| Q30439922 | Cellular signaling by fibroblast growth factors (FGFs) and their receptors (FGFRs) in male reproduction |
| Q36561672 | Cellular transformation and malignancy induced by ras require c-jun |
| Q41444057 | Characterization of a delayed early serum response region |
| Q28362417 | Characterization of the MN/CA 9 promoter proximal region: a role for specificity protein (SP) and activator protein 1 (AP1) factors |
| Q38324655 | Collagenase 3 is a target of Cbfa1, a transcription factor of the runt gene family involved in bone formation |
| Q40411319 | Compilation of vertebrate-encoded transcription factors |
| Q36535741 | Components of the nuclear signaling cascade that regulate collagenase gene expression in response to integrin-derived signals |
| Q36569036 | Constitutive activation of NF-kappaB during progression of breast cancer to hormone-independent growth |
| Q42049693 | Correlated expression of matrix metalloproteinases and ets family transcription factor E1A-F in invasive oral squamous-cell-carcinoma-derived cell lines |
| Q36796980 | Cysteine-rich protein 61 (CCN1) domain-specific stimulation of matrix metalloproteinase-1 expression through αVβ3 integrin in human skin fibroblasts |
| Q40519768 | Cytoskeletal reorganization and TPA differently modify AP-1 to induce the urokinase-type plasminogen activator gene in LLC-PK1 cells |
| Q35198859 | Defective trophoblast function in mice with a targeted mutation of Ets2. |
| Q35938309 | Different binding site requirements for binding and activation for the bipartite enhancer factor EF-1A |
| Q36694226 | Direct transcriptional stimulation of the ornithine decarboxylase gene by Fos in PC12 cells but not in fibroblasts |
| Q36161077 | Drosophila screening model for metastasis: Semaphorin 5c is required for l(2)gl cancer phenotype |
| Q33638827 | ETS-targeted therapy: can it substitute for MEK inhibitors? |
| Q38949808 | ETS1 is a genome-wide effector of RAS/ERK signaling in epithelial cells |
| Q35829772 | Enhancer-mediated role for polyomavirus middle T/small T in DNA replication. |
| Q40412401 | Ets transcription factor binding site is required for positive and TNF alpha-induced negative promoter regulation. |
| Q38293503 | Ets-1 is involved in transcriptional regulation of the chick inducible nitric oxide synthase gene in embryonic ventricular myocytes |
| Q36815047 | Expression of a 91-kilodalton PEA3-binding protein is down-regulated during differentiation of F9 embryonal carcinoma cells |
| Q73564842 | Expression of c-ets-1 mRNA is associated with an invasive, EMT-derived phenotype in breast carcinoma cell lines |
| Q42022050 | Expression of c-ets-1, collagenase 1, and urokinase-type plasminogen activator genes in lung carcinomas |
| Q36155328 | Expression of maspin in prostate cells is regulated by a positive ets element and a negative hormonal responsive element site recognized by androgen receptor |
| Q28628647 | Extracellular matrix and integrin signalling: the shape of things to come |
| Q38946378 | Extracellular signal-regulated kinase signaling regulates the opposing roles of JUN family transcription factors at ETS/AP-1 sites and in cell migration |
| Q42940092 | Fra-1 regulation of Matrix Metallopeptidase-1 (MMP-1) in metastatic variants of MDA-MB-231 breast cancer cells |
| Q24541389 | Functional cross-antagonism between transcription factors FLI-1 and EKLF |
| Q36966973 | HGF-MET signals via the MLL-ETS2 complex in hepatocellular carcinoma |
| Q46563144 | Harpagoside suppresses IL-6 expression in primary human osteoarthritis chondrocytes |
| Q34143433 | Heparin inhibits the induction of three matrix metalloproteinases (stromelysin, 92-kD gelatinase, and collagenase) in primate arterial smooth muscle cells. |
| Q29620360 | How matrix metalloproteinases regulate cell behavior |
| Q42787871 | Human skin in organ culture. Elaboration of proteolytic enzymes in the presence and absence of exogenous growth factors. |
| Q33594115 | Hyperglycemia, a neglected factor during cancer progression |
| Q36670051 | Identification of ETS domain proteins in murine T lymphocytes that interact with the Moloney murine leukemia virus enhancer |
| Q33868881 | Identification of a new sea urchin ets protein, SpEts4, by yeast one-hybrid screening with the hatching enzyme promoter |
| Q41945472 | Identification of a novel interleukin-6 response element containing an Ets-binding site and a CRE-like site in the junB promoter |
| Q37366200 | Induction of MMP-1 (collagenase-1) by relaxin in fibrocartilaginous cells requires both the AP-1 and PEA-3 promoter sites |
| Q28343521 | Inhibition of gelatinase activity in human airway epithelial cells and fibroblasts by dexamethasone and beclomethasone |
| Q36683988 | Interaction of nuclear factor EF-1A with the polyomavirus enhancer region |
| Q38328562 | Interference between pathway-specific transcription factors: glucocorticoids antagonize phorbol ester-induced AP-1 activity without altering AP-1 site occupation in vivo |
| Q40530948 | Interleukin-1 or phorbol induction of the stromelysin promoter requires an element that cooperates with AP-1. |
| Q38583149 | Interleukin-4 suppression of interleukin-1-induced transcription of collagenase (MMP-1) and stromelysin 1 (MMP-3) in human synovial fibroblasts. |
| Q36693710 | Inverse PCR-mediated cloning of the promoter for the rat vasopressin V2 receptor gene |
| Q72347476 | Investigation of the relationship between osteoporosis and the collagenase gene by means of polymorphism of the 5'upstream region of this gene |
| Q38579800 | Journey to the surface of the cell: Fos regulation and the SRE |
| Q36697994 | Late promoter of human papillomavirus type 8 and its regulation |
| Q41062169 | Mammary tumors induced by polyomavirus |
| Q37579014 | Matrix-degrading metalloproteinases in photoaging |
| Q38353062 | Melanotransferrin gene expression in melanoma cells is correlated with high levels of Jun/Fos family transcripts and with the presence of a specific AP1-dependent ternary complex |
| Q24646365 | Meprins, membrane-bound and secreted astacin metalloproteinases |
| Q38314720 | Molecular regulation of the human IL-3 gene: inducible T cell-restricted expression requires intact AP-1 and Elf-1 nuclear protein binding sites |
| Q37354291 | Monocytic cell type-specific transcriptional induction of collagenase |
| Q38352046 | Myb-Ets fusion oncoprotein inhibits thyroid hormone receptor/c-ErbA and retinoic acid receptor functions: a novel mechanism of action for leukemogenic transformation by E26 avian retrovirus |
| Q37558151 | Oncogene activation of human keratin 18 transcription via the Ras signal transduction pathway |
| Q73348982 | Oxidized LDL inhibits vascular endothelial cell morphogenesis in culture |
| Q35092834 | PEA3 sites within the progression elevated gene-3 (PEG-3) promoter and mitogen-activated protein kinase contribute to differential PEG-3 expression in Ha-ras and v-raf oncogene transformed rat embryo cells |
| Q36686165 | Physical and functional characterization of transcriptional control elements in the equine infectious anemia virus promoter |
| Q28581964 | Physiological loading of joints prevents cartilage degradation through CITED2 |
| Q42497408 | Promoter elements in the transcriptional activation of the human stromelysin-1 gene by the inflammatory cytokine, interleukin 1. |
| Q41879970 | RAS/ERK pathway transcriptional regulation through ETS/AP-1 binding sites |
| Q40022010 | Rapid phosphorylation of Ets-2 accompanies mitogen-activated protein kinase activation and the induction of heparin-binding epidermal growth factor gene expression by oncogenic Raf-1. |
| Q33889041 | Regulation of eosinophil-specific gene expression by a C/EBP-Ets complex and GATA-1. |
| Q36552106 | Regulation of urokinase-type plasminogen activator gene transcription by macrophage colony-stimulating factor. |
| Q41432406 | Retroviral mediated gene transfer in megakaryocytic cell lines |
| Q38321462 | Role of distinct mitogen-activated protein kinase pathways and cooperation between Ets-2, ATF-2, and Jun family members in human urokinase-type plasminogen activator gene induction by interleukin-1 and tetradecanoyl phorbol acetate |
| Q35788022 | Role of the Ets-1 transcription factor during activation of rat hepatic stellate cells in culture. |
| Q40511441 | Role of the extracellular matrix in the degradation of connective tissue |
| Q40966018 | Selective loss of PMA-stimulated expression of matrix metalloproteinase 1 in HaCaT keratinocytes is correlated with the inability to induce mitogen-activated protein family kinases |
| Q40547731 | Serum, AP-1 and Ets-1 stimulate the human ets-1 promoter |
| Q30398272 | Small molecule inhibitors targeting activator protein 1 (AP-1). |
| Q38295315 | Structural organization and chromosomal localization of the mouse collagenase type I gene |
| Q36479295 | The Ets1 transcription factor is widely expressed during murine embryo development and is associated with mesodermal cells involved in morphogenetic processes such as organ formation |
| Q38321239 | The NFAT-1 DNA binding complex in activated T cells contains Fra-1 and JunB. |
| Q36649828 | The PU.1/Spi-1 proto-oncogene is a transcriptional regulator of a lentivirus promoter |
| Q41080680 | The c-Ets oncoprotein activates the stromelysin promoter through the same elements as several non-nuclear oncoproteins |
| Q24620542 | The extracellular matrix ligands fibronectin and tenascin collaborate in regulating collagenase gene expression in fibroblasts |
| Q47636089 | The human aldehyde dehydrogenase 3 gene (ALDH3): identification of a new exon and diverse mRNA isoforms, and functional analysis of the promoter. |
| Q36843122 | The multisubstrate docking site of the MET receptor is dispensable for MET-mediated RAS signaling and cell scattering. |
| Q36528077 | The role of APE/Ref-1 signaling pathway in hepatocellular carcinoma progression |
| Q47678313 | Thyroid hormone-dependent expression of bullfrog tadpole collagenase gene |
| Q40406568 | Transactivation of mouse insulin-like growth factor II (IGF-II) gene promoters by the AP-1 complex. |
| Q40523285 | Transcription factor PEA3 participates in the induction of urokinase plasminogen activator transcription in murine keratinocytes stimulated with epidermal growth factor or phorbol-ester |
| Q40678426 | Transcriptional activation of the CEF-4/9E3 cytokine gene by pp60v-src |
| Q36747690 | Transcriptional activation through ETS domain binding sites in the cytochrome c oxidase subunit IV gene |
| Q36685904 | Transcriptional downregulation of the retina-specific QR1 gene by pp60v-src and identification of a novel v-src-responsive unit |
| Q33923496 | Transcriptional regulation of matrix metalloproteinase-1 and collagen 1A2 explains the anti-fibrotic effect exerted by proteasome inhibition in human dermal fibroblasts |
| Q36617312 | Transcriptional repression of the human collagenase-1 (MMP-1) gene in MDA231 breast cancer cells by all-trans-retinoic acid requires distal regions of the promoter |
| Q36555302 | Transcriptional stimulation of the retina-specific QR1 gene upon growth arrest involves a Maf-related protein |
| Q36745387 | Transforming growth factor alpha induces collagen degradation and cell migration in differentiating human epidermal raft cultures |
| Q40678620 | Transforming growth factor beta 1-responsive element: closely associated binding sites for USF and CCAAT-binding transcription factor-nuclear factor I in the type 1 plasminogen activator inhibitor gene |
| Q41056860 | Tumor cell contact mediated transcriptional activation of the fibroblast matrix metalloproteinase-9 gene: involvement of multiple transcription factors including Ets and an alternating purine-pyrimidine repeat |
| Q55401040 | Two transcription factors, E1AF and N-myc, correlate with the invasiveness of neuroblastoma cell lines. |
| Q73690325 | Up-regulation of matrix metalloproteinase-1 expression in U937 cells by low-density lipoprotein-containing immune complexes requires the activator protein-1 and the Ets motifs in the distal and the proximal promoter regions |
| Q40656379 | XrpFI, an amphibian transcription factor composed of multiple polypeptides immunologically related to the GA-binding protein alpha and beta subunits, is differentially expressed during Xenopus laevis development |
| Q35830887 | c-ets1 proto-oncogene is a transcription factor expressed in endothelial cells during tumor vascularization and other forms of angiogenesis in humans |
| Q36666887 | v-src induction of the TIS10/PGS2 prostaglandin synthase gene is mediated by an ATF/CRE transcription response element |
Search more.